botanical
What it isPlant alkaloid with AMPK activation and modest glucose and lipid lowering.
Why this oneIts glycemic effect approaches that of low-dose metformin in trials, which is unusual for a supplement.
What limits itIt is a moderate CYP3A4 and CYP2D6 inhibitor, so interactions are real. Product content is unregulated.
NO BOXED WARNINGS
Principal riskModerate CYP3A4 and CYP2D6 inhibition; unregulated content

Open Berberine in the interactive console ↗
